HIV & AIDS

Naltrexone implant helps HIV patients prevent opioid relapse

(HealthDay)—Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.

Medications

Smart pill bottle heads to clinical trials

Patented at The University of Alabama in Huntsville, (UAH), a smart pill bottle that notifies you to take your medications or reminds you if you missed a dose could be en route to medicine cabinets as soon as 2015.

HIV & AIDS

New drug adds to arsenal against AIDS

A new drug, rilpivirine, can add powerfully to the combination of medications used to control HIV for first-time patients, researchers conclude in Friday's issue of The Lancet.

page 8 from 31